quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:20:20·252d
SECFiling
ReShape Lifesciences Inc. logo

SEC Form 10-Q filed by ReShape Lifesciences Inc.

RSLS· ReShape Lifesciences Inc.
Health Care
Original source

Companies

  • RSLS
    ReShape Lifesciences Inc.
    Health Care

Recent analyst ratings

  • Oct 8UpdateMaxim Group$8.00

Related

  • SEC246d
    ReShape Lifesciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
  • SEC246d
    SEC Form 424B5 filed by ReShape Lifesciences Inc.
  • SEC247d
    ReShape Lifesciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
  • PR252d
    Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow
  • PR253d
    Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
  • PR254d
    Vyome Announces New Board of Directors with Deep MIT and AI Ties
  • SEC255d
    ReShape Lifesciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
  • PR259d
    ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022